Events

Welcome to Medicon Valley Alliance Microbiome Network and our 3rd meeting! Searching for Academic-Industrial collaborations: Microbiome workshop event Our ambition with the MVA Microbiome Network is to increase opportunities for microbiome researchers from industry and academia to meet and collaborate. In line

On March 5, 2019, the acclaimed MIT professor Dr. Feng Zhang visits BioInnovation Institute for an exclusive first event of BII’s ‘Talks on the Square’ event series. At the event, Dr. Zhang will present his work of harnessing microbial diversity

Biologics World Nordic 2019 will be the only focused biologic drugs and vaccines conference in the Nordic region. We will bring together the complete network of the Nordic biologics industry including region’s smaller Biopharmas, Big Pharmas, International Biopharmas, CMOs, CROs,

The pharmaceutical industry continues to experience decreasing productivity and high levels of attrition. Inflation of molecule physicochemical properties and complexities in clinical trial protocols stand among the main reasons for these trends. The most successful companies can leverage different expertise,

En möjlighet för dig som investerare att möta intressanta bolag. Sedermeradagen Köpenhamn den 12 mars 2019 är en investerardag där du får tillfälle att möta intressanta bolag inom micro- och smallcapsegmentet. Ditt deltagande är kostnadsfritt. Date: 12 mar 2019 Time: 11:00 –

For the sixth year in a row you are invited to interact around research and innovation in the oncology area. How can new ideas be created by working cross borders? How can industry, academia and healthcare sector work together? Date: 13 March,

In March 2019, a business conference focusing on health tech and pharma medical will be held in Shangyu outside Shanghai. Nordicflexhouse have many years of strategic partnership with the Shangyu government and the Zhejiang province. The conference will provide the opportunity for

There is no doubt that the UK’s life sciences sector is exposed to Brexit. The close integration of the UK’s regulatory and research environment with the EU and the international nature of the sector means that separation is likely to

The pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems. However, many of the drugs in the development pipelines often